These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 20521781

  • 1. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P, Mackova E, Haskova P, Vavrova A, Jirkovsky E, Sterba M, Popelova O, Kalinowski DS, Kovarikova P, Vavrova K, Richardson DR, Simunek T.
    Chem Res Toxicol; 2010 Jun 21; 23(6):1105-14. PubMed ID: 20521781
    [Abstract] [Full Text] [Related]

  • 2. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
    Simůnek T, Boer C, Bouwman RA, Vlasblom R, Versteilen AM, Sterba M, Gersl V, Hrdina R, Ponka P, de Lange JJ, Paulus WJ, Musters RJ.
    J Mol Cell Cardiol; 2005 Aug 21; 39(2):345-54. PubMed ID: 15978614
    [Abstract] [Full Text] [Related]

  • 3. Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity.
    Hašková P, Koubková L, Vávrová A, Macková E, Hrušková K, Kovaříková P, Vávrová K, Simůnek T.
    Toxicology; 2011 Nov 18; 289(2-3):122-31. PubMed ID: 21864640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
    Hašková P, Kovaříková P, Koubková L, Vávrová A, Macková E, Simůnek T.
    Free Radic Biol Med; 2011 Feb 15; 50(4):537-49. PubMed ID: 21147217
    [Abstract] [Full Text] [Related]

  • 6. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
    Macková E, Hrušková K, Bendová P, Vávrová A, Jansová H, Hašková P, Kovaříková P, Vávrová K, Simůnek T.
    Chem Biol Interact; 2012 May 30; 197(2-3):69-79. PubMed ID: 22521999
    [Abstract] [Full Text] [Related]

  • 7. Iron chelators can protect against oxidative stress through ferryl heme reduction.
    Reeder BJ, Hider RC, Wilson MT.
    Free Radic Biol Med; 2008 Feb 01; 44(3):264-73. PubMed ID: 18215735
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H, den Hartog GJ, Simůnek T, Schröterová L, Kvasnicková E, Bast A.
    Br J Pharmacol; 2006 Dec 01; 149(7):920-30. PubMed ID: 17031387
    [Abstract] [Full Text] [Related]

  • 10. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T, Gustafsson B, Brunk UT.
    FEBS J; 2006 Jul 01; 273(13):3106-17. PubMed ID: 16762036
    [Abstract] [Full Text] [Related]

  • 11. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
    Jansová H, Macháček M, Wang Q, Hašková P, Jirkovská A, Potůčková E, Kielar F, Franz KJ, Simůnek T.
    Free Radic Biol Med; 2014 Sep 01; 74():210-21. PubMed ID: 24992833
    [Abstract] [Full Text] [Related]

  • 12. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N, Buss JL, Soe-Lin S, Felfly H, Trudel M, Ponka P.
    Exp Hematol; 2008 Jul 01; 36(7):773-85. PubMed ID: 18456387
    [Abstract] [Full Text] [Related]

  • 13. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
    Jansová H, Kubeš J, Reimerová P, Štěrbová-Kovaříková P, Roh J, Šimůnek T.
    Chem Res Toxicol; 2018 Nov 19; 31(11):1151-1163. PubMed ID: 30395451
    [Abstract] [Full Text] [Related]

  • 14. Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine.
    Hašková P, Applová L, Jansová H, Homola P, Franz KJ, Vávrová K, Roh J, Šimůnek T.
    Sci Rep; 2022 Jun 13; 12(1):9765. PubMed ID: 35697900
    [Abstract] [Full Text] [Related]

  • 15. Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.
    Kalinowski DS, Richardson DR.
    Chem Res Toxicol; 2007 May 13; 20(5):715-20. PubMed ID: 17402750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells.
    Jayasena T, Grant RS, Keerthisinghe N, Solaja I, Smythe GA.
    Neurosci Res; 2007 Mar 13; 57(3):454-61. PubMed ID: 17210195
    [Abstract] [Full Text] [Related]

  • 18. New iron chelators in anthracycline-induced cardiotoxicity.
    Kaiserová H, Simunek T, Sterba M, den Hartog GJ, Schröterová L, Popelová O, Gersl V, Kvasnicková E, Bast A.
    Cardiovasc Toxicol; 2007 Mar 13; 7(2):145-50. PubMed ID: 17652820
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.
    Becker EM, Lovejoy DB, Greer JM, Watts R, Richardson DR.
    Br J Pharmacol; 2003 Mar 13; 138(5):819-30. PubMed ID: 12642383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.